Related by context. All words. (Click for frequent words.) 58 PRODUCT DISCLOSURE STATEMENT 56 #.#-# b [002] 56 THE OFFER .oriental spices 56 cmt 55 ERRED WHEN IT 55 Topics Covered I. INTRODUCTION 55 Income Tax Regs 55 CAPITAL EXPENDITURE 55 FINANCIAL RISK MANAGEMENT 54 TRUST PLC 54 GROWTH FUND 54 Sports Exerc 54 한 54 J Pediatr 54 SMARTREND NEWS 53 PARAGRAPH 53 CORPORATE GOVERNANCE STATEMENT 53 END USE 53 I. INTRODUCTION METHODOLOGY 52 J Am Soc 52 tfn loc 52 CONFINDUSTRIA 52 doi #.# 52 LIPID 52 patrick.graham @ thomson.com 52 MARKET SIZE 51 pjg 51 FASEB J. 51 PLATE Div.I #,# 51 PROFILE OF 51 GROUP LIMITED ABN 51 :5 51 WpHG mit dem Ziel 51 OVERVIEW OF 51 FI . 51 Toxicol 51 Rs.# w 51 Obes Res 50 POL PRO 50 Curr Opin 50 See id 50 INEFFECTIVE ASSISTANCE OF COUNSEL 50 IVQ 50 50 CARLETON COLLEGE 50 ANNEXURE B 50 EVALUATE 50 J Am Coll 50 Content Outline 50 και 50 Nat Clin Pract 50 INTRODUCTION I. 50 Am J Clin 50 DEGNAN 50 Def. s 50 J Rheumatol 49 Nephrol Dial Transplant 49 eget 49 TUMORS 49 J Clin Psychiatry 49 CRITERIA 49 Gynecol 49 CFR #.#b 49 ALEX SHELLEY 49 INTERIM REPORT 49 J Clin Oncol 49 § #-#-# b [003] 49 MARKET OUTLOOK 49 Certifications Commercial Items 49 #S #S [003] 49 Capitalisation 48 Legal #.# 48 ps :# 48 NJSA 2C :5 48 Pl. 48 = sizeof 48 Biol Phys 48 OF NATIONS 48 EXECUTIVE SUMMARY 48 Clin Oncol 48 :3 48 Metab Disord 48 Psychosom Med 48 PAINTER T. 48 Free Full Text 48 Cardiol 48 Takeovers Regulations 48 с 48 RECORDATI 48 Suppl 48 alex.brittain @ thomson.com abr 48 NJSA 2C :2 48 LW * LW# 48 Suomen Terveystalo Oyj 48 Arch Facial Plast 48 Arch Dermatol 48 Ann Oncol 48 Cancer Res 48 INVESTMENT FUND 48 NOT FDIC NCUA 48 INTERIM FINANCIAL STATEMENTS 48 Suppl. 48 Brief Description 48 ANNEXURE 48 Ra2 47 Qa5 + 47 OTHER MATTERS 47 Biol Psychiatry 47 newsdesk@afxnews.com mn 47 -Dariusz Snarski 47 Rheumatol 47 Ann Rheum Dis 47 KAVERI 47 SORT OUT 47 z z 47 미국 의 47 Este año 47 dak li 47 ms1 47 Pl. s 47 :2 47 iaculis 47 Gynecol Oncol 47 #.#/journal.pmed.# 47 CAPITAL TRUST 47 J Foot Ankle 47 facilisis 47 KEY FIGURES 47 Non Responders 47 Eur Urol 47 § #E 47 BEST PRACTICE 47 Urol 47 CFR #.# [002] 47 Quartal 47 RELEASE ACCORDING TO 47 kienu 47 WPHG 47 NWLR PT 47 Double Blind Randomized 47 Arch Intern Med 47 BLN EUROS 47 % du produit 47 By DENES HUSTY 47 BOVESPA AMIL3 47 :9 46 Randomized Controlled Trials 46 INDICES 46 ¼ l 46 newsdesk@afxnews.com ml 46 Defs. 46 efficace 46 KEMIRA 46 MAINTENANCE TECH 46 arcu 46 semestre 46 CFR § #.# [006] 46 INFRASTRUCTURE FUND 46 Def. 46 ligula 46 J Allergy Clin 46 Counterparty Criteria 46 LIST OF FIGURES 46 USC § #a [002] 46 Ann Intern Med 46 Thromb Haemost 46 tfn.europemadrid @ thomson.com ccs 46 Eur Respir J 46 SWOT ANALYSIS 46 BENETTON 46 orion 46 Nurs 46 orci 46 Analogues 46 Randomized Clinical Trial 46 fringilla 46 #PCT 46 G. Mallia 46 ALLIANCEBERNSTEIN 46 Crit Care 46 Aliquam 46 dpa nr 46 Arch Neurol 46 J Affect Disord 46 la forma 45 sh hd 45 APPENDIX 4D 45 ACCUMULATE 45 :4 45 dpa sch 45 Tipranavir 45 #-#/#L #/#L 45 S1 S# [001] 45 Proc Am Soc 45 steve.whitehouse @ thomson.com sw 45 #/#/à = I 45 CFR § #.# [007] 45 Lg nk 45 tincidunt 45 TROPHY Div. 45 SAMARAS 45 Folgen 45 vjt 45 By Denes Husty 45 tortor 45 PREFERRED QUALIFICATIONS 45 newsdesk@afxnews.com fjb 45 TRANSFORMS 45 newsdesk@afxnews.com afp 45 C.1 45 Cholinesterase Inhibitors 45 WORKING GROUP 45 J Child Adolesc 45 FINANCIAL PROMOTION ORDER 45 #.#-# [006] 45 Neurosci 45 ADONIS 45 Randomized Clinical Trials 45 abstr 45 monicca.egoy @ thomson.com mbe 45 END FOOTNOTE FOOTNOTE 45 newsdesk@afxnews.com faj 45 SHILPA 45 dpa ms 45 CHIEF INVESTMENT OFFICER 45 CFR § #.# [004] 45 § #.#-# [004] 45 Tangible Equity 45 purus 45 Randomized Double Blind Placebo 45 CFR § #.# [002] 45 DELINQUENT LOANS 45 THE MIZ 45 A.Market Analysis 45 pawel.sobczak @ thomson.com 45 Confirmatory Phase 45 dpa rt 44 #/#L #-#/#L 44 Eur J Cancer 44 Cilostazol 44 wjh 44 dpa hw 44 #-#.# BID 44 NTQ 44 USC § #u 44 BASEL II 44 PREMIUM INCOME 44 Neurol 44 Corporate Governance Principles 44 CREDIT AGRICOLE 44 CHAMPIONS LEAGUE LIVERPOOL 44 bxc5 44 dpa ff 44 AUTOMATIC WITH OVERDRIVE 44 III • dhusty@news-press.com 44 #OHD 44 Nat Genet 44 Int J Epidemiol 44 PRIVATE BANKING 44 dpa fm 44 #:#-# [037] 44 MONDAY FEB 44 STAFF WRITER @ tidewaternews.com 44 BAST 44 #.Bb# a6 Nf6 #.#-# 44 ¾ l 44 METIS 44 II MARKET ENVIRONMENT 44 J Urol 44 Clinical Outcome 44 CELGENE 44 scs 44 BASLE 44 CALAMOS 44 USC § #c 44 Vasc 44 dpa db 44 microg 44 dpa sib 44 dpa kr 44 dpa lsm 43 IYER 43 dpa sm 43 Oral Fingolimod 43 weighted avg 43 EURIDIS 43 [013] 43 p FP 43 iii iv 43 Ranolazine 43 Kb1 43 bxc3 43 kollox 43 By D. Scriber 43 E. Mbong 43 jrw 43 Load Structure 43 dpa sk 43 Br J Cancer 43 M anagement 43 J Endocrinol 43 Judgments § 43 Clin Endocrinol 43 #w #S 43 Trapeza CDO 43 Marion Bartoli FRA 43 Novel Inhibitor 43 Betaferon R 43 EBITDA MARGIN EXPANSION 43 Observational Studies 43 REVENUE BY OPERATOR 43 BENCHMRK 43 #.cxd# [002] 43 OWN GOAL 43 dpa wh 43 Neurobiol 43 в 43 BY DOUGLAS HANKS 43 :8 43 Table SECTION 43 J Orthop 43 #b #S 43 Opp'n 43 COMMERZBANK 42 len = 42 FOR AN OPEN 42 BasWare Corporation 42 = null 42 INTESA SANPAOLO 42 Vestibulum 42 argc 42 #ff [001] 42 Diabet Med 42 Segmental Analysis 42 Ke3 42 Trandolapril 42 J Clin Psychopharmacol 42 dpa tg 42 Joel Roelants BEL KTM 42 deoxy 42 lorem 42 Intravenous Equipment 42 C. Sciberras 42 quis 42 CFR pt 42 AOQ MT 42 basel 42 1L #-#/#L 42 Bxc6 42 twd ccg 42 Radiol 42 Osteoporos Int 42 Siemens Aktiengesellschaft 42 DOSAGE AND ADMINISTRATION 42 dpa ac 42 document.write unescape % 42 hdfc 42 - -Vader costume 42 NZPA WGT 42 Efficiency ratio FTE 42 Psychiatr Serv 42 HMQ MT 42 Qxf3 42 -mother Arndrea 42 Oral Presentation # 42 xi haga 42 SIGNIFICANT ACCOUNTING POLICIES 42 AUC0 42 #S #w 42 ITAU 42 giugno 42 R. Bajada 42 Bxc3 + 42 FROM OFFICIAL SOURCES 42 ,8 42 Kim Clijsters Bel 42 :7 42 Ruhel date 42 CHAMPIONS LEAGUE MANCHESTER UNITED 42 Fujitsu Siemens Computers PRIMEPOWER 42 Eugene Laverty IRL Parkalgar 42 #a# [003] 42 DWS RREEF 42 CHAMPIONS LEAGUE CHELSEA 42 shaPE Capital AG 42 Davide Guarneri ITA Yamaha 41 Raw #/#/# Punjab 41 VEDANTA 41 i te tau 41 KOFI KINGSTON 41 hxg4 41 controlled multicenter Phase 41 I. Zammit 41 Figure S2 41 Histone Deacetylase 41 NORDEA BANK AB 41 SPIRIVA ® 41 dpa hl 41 tHe 41 unsigned char 41 enim 41 -2 -3 41 Ann Emerg Med 41 bowel syndrome IBS 41 sUA 41 PEY 41 Randomized controlled 41 #:#-# [018] 41 Tst 41 GENERALI 41 Vera Zvonareva RUS 41 ACE Inhibitor 41 #.d# d5 41 AAAmmf 41 i primi 41 dpa jb 41 C. SINGLETON 41 Contents Introduction 41 Sebastien Pourcel FRA Kawasaki 41 AUTOMATIC SEQUENTIAL PORT 41 Skidmore . 41 dpa cp 41 M Models Excluded 41 MiFID PCI GLBA 41 des marchés 41 T. Cilia 41 #.Nf# [001] 41 de la vente des 41 #:#-# Abstract Free [003] 41 unfractionated heparin UFH 41 J Psychiatry 41 Wtd 41 COPERNICUS 41 ICICI Pru MF 41 Mhux 40 dpa dg 40 ALESCO 40 cmm 40 Informationstechnologie 40 dpa rl 40 Sht nk 40 FRESENIUS 40 Joshua Coppins NZL Yamaha 40 Alexey Kedriouk Kaz 40 dpa ry 40 pimecrolimus cream 40 TORGERSON 40 Steven Frossard FRA Kawasaki 40 I. INTRODUCTION 40 jrw ccg 40 Keywords MARKETS STOCKS 40 Initiated Phase 40 qabel 40 RE SPEARS 40 NSABP B 40 iva 40 antitrypsin 40 J. Debattista 40 Quarterly Interval Plan 40 Jelena Jankovic SRB 40 Rxf6 40 Internal Capital Adequacy 40 tellus 40 Cropredy Res 40 dpa si 40 TELEPERFORMANCE 40 Competitive Scenario 40 Maximilian Nagl GER KTM 40 Solvency II Basel 40 border="0" 40 Randomized Phase II 40 lifts NEW JERSEY 40 SC Chang enditem 40 reflux esophagitis 40 Debenture Issue 40 seq 40 Teflaro treated 40 mg qd 40 Posaconazole 40 Mol Psychiatry 39 dawk li 39 Prospective Randomized Trial 39 tbsp lemon juice 39 dollari 39 Be2 39 #Table [003] 39 PEG IFN 39 -#.# log# 39 tsp vanilla extract 39 Weightings 39 Dose Ranging 39 K. Sammut 39 LIST OF TABLES 39 Fecal Incontinence 39 ya na 39 abbr 39 Qb5 39 efavirenz EFV 39 Y Y -#.# 39 SEBI Delisting 39 Canara Robeco MF 39 PIMCO Municipal Income 39 Capital Adequacy 39 Antiviral Therapy 39 adjuvant trastuzumab 39 SOCIAL DANCE 39 WALKER Marcedes 39 Splendid Medien AG 39 Sciens 39 Chen Jin Chn 39 LIST OF TABLES Table 39 Annexures 39 Brahma Sutra 39 Kaz bt 39 Francesca Schiavone ITA 39 Ž 39 Statutory Accounting Principles 39 BY GUILLERMO 39 Non Dilutive 39 xsl template 39 LEAGUE DIVISION 39 idx 39 Gastric Cancer 39 HCV SPRINT 39 Non Inferiority 39 Etienne Bacrot Fra 38 Nilotinib 38 dpa sar 38 Hazard Ratio 38 ACTEMRA TM 38 PRISMA 38 Randomised 38 Tick Size 38 Pivotal Phase II 38 #:#-# Abstract Free [007] 38 KG Subraya Sharma 38 document.getElementById 38 Pressure Monitoring 38 Tomas Berdych CZE 38 Randomized Study 38 Elena Dementieva RUS 38 Qrtr 38 Origine 38 ECOG PS 38 multicentre randomized 38 Cinacalcet HCl 38 Exp Clin 38 BRFS 38 Dinara Safina Rus 38 Brain Metastases 38 primary percutaneous coronary 38 Topline Results 38 lhe 38 Antonio Cairoli ITA Yamaha 38 PASSAGE TO 38 Late Breaker 38 des Assurances 38 -#.# ± [002] 38 RC #.# B [001] 38 denna 38 OPTIMIZE 38 fid 38 Disorders SCID 38 #-#/# [013] 38 #:#-# Abstract Free [001] 38 #:# -# Abstract Free [001] 38 - MARKET SNAPSHOT [002] 38 BENICAR HCT 38 cashout refinances account 38 d4 d5 38 Reiki Level 38 Qe3 38 ALLEN POWELL 38 arket 38 mmj 38 Stapling Proposal 38 Practical Aspects 38 TAKEDA 38 Consensus +#.# 37 LADDER MATCH 37 Stent Restenosis 37 CRD3 37 Organizational Restructuring 37 Regular Quarterly 37 matière 37 Randomized phase 37 Semester Examination 37 Lung Cancer Trial 37 Xian Lu 37 Emkay maintains 37 G. CHAMBERS WILLIAMS 37 Semester Exam 37 Canara Robeco Balance 37 Randomized Phase III 37 MADRS score 37 ACC AHA 37 JACK HILL 37 NHDP Phase 37 μg kg 37 HLA DRB1 * 37 Loek van Wely Ned 37 International Prognostic Scoring 37 Yu Chn 37 Evaluation Criteria 37 Soy Isoflavones 37 TAG Tegernsee Immobilien und 37 By Linwood Outlaw 37 lopinavir r arm 37 Ref. 37 PCAOB Auditing Standard 37 ZYBRESTAT TM 37 somatostatin analog 37 Bc4 36 MACQUARIE DEVELOPMENT CAPITAL 36 Nimble Feet 36 Ruhel Chisty MRACI 36 SWZ 36 ID nBMA# 36 - Non GAAP [031] 36 neuropathy sensory 36 baseline serum creatinine 36 E.2 36 Gastrointestinal Stromal Tumors 36 ICICI Prudential Interval 36 Q Chem 36 Unnim 36 Nd6 36 bhala 36 Teimour Radjabov Aze 36 Tf 36 randomized multicenter 36 LP# [001] 36 Cbe 36 III.#.# 36 Primary Efficacy Endpoint 36 thrombosis embolism 36 Janko Tipsarevic SRB 36 GLOBAL MARKET PERSPECTIVE 36 S. Harini 36 DREW UNIVERSITY 36 GW MILLER 36 prospective multicentre 36 C BASS CBO 36 #.Bb# [001] 36 Puma VCT 36 MARKETING STRATEGIES 36 Standardized Approach 36 RH DONNELLEY CORPORATION 36 ‰ ¥ 36 Emanuele flied 36 Meaningful Use Stage 35 CAMELS rating 35 ART THOMPSON 35 Quartile 35 cnd 35 mw END 35 BENICAR 35 Polyphenon R 35 Zeitschrift für 35 Wachstum 35 ò 35 apolipoprotein B 35 DURATION 35 Papillary 35 Cardiotoxicity 35 ElringKlinger AG 35 EndoTAG 35 Franklin Templeton MF 35 RECENT INDUSTRY ACTIVITY 35 JNTU Kakinada 35 genotype 1a 35 Product Introductions Innovations 35 Exs 35 Finacea 35 #:# -# Abstract Free [002] 35 multicenter phase 35 GATT Article 35 STATE STREET CORPORATION 35 WILLIAM REGAL 35 Dinara Safina RUS 35 Patty Schnyder SUI 35 Wkly 35 OMX Nordic List 35 GRAPH 35 Castration Resistant Prostate Cancer 35 Svetlana Kuznetsova RUS 35 MTBC EMR 35 SET# [001] 35 Wang Yue Chn 35 photoprotective drug 35 KOOS 35 ACCLAIM COPD 35 icatibant 35 LUCAS L. JOHNSON 35 Cie AG 35 PCWP 35 Capital Adequacy Framework 34 BOBL 34 randomized controlled Phase 34 NovoMix 34 credit suisse 34 Stage IIB 34 benazepril 34 Supplementary Table 34 FLY Leasing 34 multicenter multinational 34 Oral Session 34 Magnus Carlsen Nor 34 Miniratna 34 hematological parameters 34 cmp 34 Define Measure 34 Metastatic Renal Cell Carcinoma 34 Basel Accord 34 EUR# Billion 34 Downing Protected VCT 34 Brésil 34 Oracle Reveleus 34 = #.#f 34 IBIs 34 effet 34 Infl 34 Meta analyzes 34 ICICI Prudential MF 34 T1a 34 ID nMDT# 34 MR Sangeetha 34 Lingfield 5f 2yo mdn 34 Bivalirudin 34 XIENCE TM 34 Expert Consensus 34 Breast Ultrasound 34 Allbanc Split Corp. 34 ATOSS Software AG 34 Chola MF 34 REUTERS Claro Cortes 34 Adjusted Margin 34 xiv inclusive 34 stage IIIB 34 Le Chatelier 34 HDL Cholesterol 33 KIID 33 Alexei Shirov Esp 33 stomatitis pharyngitis 33 height #px [002] 33 CAPITAL ACCOUNT 33 NCEP ATP III 33 BY FRANK RADOSEVICH 33 progressive dyspnea 33 BE BTech 33 hdfc equity 33 Chronic Obstructive Lung 33 Basel Accords 33 Veselin Topalov Bul 33 OSCAR WELLS GABRIEL 33 Treating Heart Failure 33 Religare MF 33 Agnieszka Radwanska POL 33 UCITS Directive 33 Arpida Ltd. 33 Adjuvant Treatment 33 Asaf Jah 33 Gopika Kapoor 33 H1 FY 33 nWNA# 33 clazosentan 33 Peter Leko Hun 33 spes 33 proliferator activated receptor 33 MDRD 33 PreTSL 33 Boris Gelfand Isr 33 ¨ ¤ 33 Edwin M. Fayia 33 HDFC Prudence 33 Collagen Type 33 Fund Quarterly Interval 33 ID nBMB# 33 2n = 33 System IPSS 33 Hybrid Capture 33 Concluding Remarks 32 CI -#.# 32 italia 32 Acute Coronary Syndromes ACS 32 TIIC 32 Viswanathan Anand Ind 32 Appendixes 32 Alexander Morozevich Rus 32 Vildagliptin 32 +2 +3 32 Complementarity 32 J Surg 32 Industry Classification Benchmark 32 len #-#/# len 32 abn amro 32 HBeAg negative patients 32 R. Arun Karthik 32 ALT elevation 32 M. HOPPER 32 diabetes dyslipidemia 32 calcium calmodulin dependent 32 5alpha reductase 32 macroalbuminuria 32 #:# #:# #:# [001] 32 G. Tracy Mehan 32 Roger DuPuis 32 Hormone Refractory Prostate Cancer 32 Strategic Rationale 32 chemoradiation therapy 32 BNS Split Corp. 32 CHF#.#B 32 ICICI Prudential Dynamic 32 ID nBOM# [002] 32 Rk 32 #.#f [002] 32 Vitality Re 32 BCom Part 32 #,#,#,# [006] 31 Oral Presentation 31 RONG GONG LIN 31 SPP# Rasilez 31 NYHA Class IV 31 CRUCELL 31 Basle II 31 +5' 31 Ruslan Ponomariov Ukr 31 Roger Federer SUI 31 Narasimham Committee 31 CORE OM 31 Atanu Lahiri 31 Multicap Fund 31 multivariate regression analysis 31 QIF 31 Industry B.1 Industry 31 online ordering paxil 31 Amruta Mokal 31 CORE Phase 31 Charles L. Dimmler 31 Itau Holding 31 FTSE Mib index 31 5-FU/LV 31 p = NS 31 EFNS 31 apo B apo AI 31 UTI Dividend Yield 31 WILEX AG 31 GITAM 31 Novavisions 31 Safinamide 31 Altor Fund 31 Rapeseed Rajasthan #/#.# # 31 Kim Clijsters BEL 31 BASEL 31 IV NSCLC 31 Suzano Petroquimica 30 Magma Shrachi 30 Drum Werks 30 multicenter randomized Phase 30 saha 30 -#.# mmol L 30 # sqf # 30 Lovaza ® 30 Vassily Ivanchuk Ukr 30 B.Com Part 30 Pareto Principle 30 lV 30 FINANCIAL MATTERS 30 #,# mn [001] 30 EndoTAG ® 30 J. Saranya 30 NYHA functional class 30 MolMed 30 alan greenspan 30 Peter Svidler Rus 30 periprocedural MI 30 Engage Analytics 30 Automne 30 SVR# 30 Counterparty Risk Management 30 ajay 30 Expansionary 30 Sunset Stroll 30 APACHE II 30 DBS Chola MF 29 Pegylated interferon 29 QIS4 29 Henry Powderly 29 amit 29 BY ART THOMPSON 29 Emerging Mkts 29 Arvind Shastry 29 de Madrid UC3M 29 interferon α 29 EQT Expansion Capital 29 papillary RCC 29 vinod 29 dlh 29 Reporter Daarel Burnette 29 satish 29 Chronicles #:# 29 Subgroup analysis 29 rohit 29 FDA defined valvulopathy 29 InfiniScale ® 29 SMITH INTERNATIONAL INC. 29 Smallcaps 29 ANCOVA 29 compatriot Marco Chiudinelli 28 S. Satyapragyan 28 ICH guidelines 28 Euro Changeover 28 CFS MK 28 NV Statutory 28 BY RICH MCCRACKEN 28 multicentre phase 28 Inflation Targeting 28 ggg 28 IIEF 28 Confidence Interval 28 Seamec 28 Anwesh Upadhyaya 28 Wale Lookin At 28 P. Maheswaran 28 echocardiographic parameters 28 UPDRS II 28 prudential 28 1Cor 28 MR Venkatesh 28 Apparel NASDAQ GIII 27 Aggrenox R 27 PDS Girinath 27 B. Challinor 27 x denotes seeding 27 Kiran Monisha Mohanty 27 PSDS 27 Sandesh Kirkire CEO 27 Christie Rizk cr vj 27 barclays 27 THE HANGOVER PART 27 hGH CTP Phase 27 B. Adhiban 27 Swati Mohota 26 ezetimibe simvastatin 26 denounce Pope Shenouda 26 Kotak Opportunities 26 essential blepharospasm 26 Corinthians #:#-# [006] 26 Basel II 26 triple nucleoside 26 pegylated liposomal doxorubicin PLD 26 Supriya Maji 25 SM9 25 TJ HEALY 25 vienna 25 WRIP City 25 Shashikant Kutwal 25 Pon N Krithika 25 Ã ~ 25 Drugs Affecting Lipid 25 M. Shyam Sundar 25 sess 25 w8 25 Morningstar www.morningstar.com 25 Martin Kady 25 William C. Eacho 25 CIIs 25 India cbank 24 BrahMos Block 24 inde 24 Internationalisation 24 REALiS SX7 Mark 24 Swathi Ghate 24 Nimmy George 24 #,# ton KDX 24 OrionGadgets HTC Shadow 23 JE Kavitha 23 Color Matrix Metering 23 sylvia 23 CORLUX potent GR 23 Multipolarity 23 Euwe 22 tri modality 22 Skyline Seekers 22 Bhagyashree Thipsay 22 EUR USD EUR JPY 22 Saptarshi Roy Chowdhury 22 Ahmad Husni Mohamad Hanadzlah 20 symbol ENP 20 HH Dorje Chang 20 hi jamie 19 Audemars Piguet QE 19 Manfest 18 His Holiness Pope Shenouda 18 Basle 17 PrepCom 17 ABCDE 16 Men Handball 16 Lizard Brains